"St. Francis Regional Medical Center provides healthcare for the people in the Twin Cities southern metro area."

During the past decade, Saint Francis Regional Medical Center conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 136 clinical trials were completed, i.e. on average, 79.1% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 71 clinical trials were completed. i.e. 97.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Francis Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 154 trials, followed by "Alliance for Clinical Trials in Oncology" with 41 trials sponsored, "SWOG Cancer Research Network" with 41 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Francis Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Saint Francis Regional Medical Center" are "Recurrent Ovarian Carcinoma" (14 trials), "Ovarian Seromucinous Carcinoma" (10 trials), "Recurrent Fallopian Tube Carcinoma" (10 trials), "Recurrent Primary Peritoneal Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Saint Francis Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Francis Regional Medical Center" are "Drug" (239 trials), "Other" (188 trials), "Biological" (118 trials), "Procedure" (72 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (102 trials), "Quality-of-Life Assessment" (80 trials), "Questionnaire Administration" (49 trials), "Paclitaxel" (39 trials) and "Carboplatin" (33 trials). Other intervention names were less common.

The vast majority of trials in "Saint Francis Regional Medical Center" are 233 trials for "All" genders, 56 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Francis Regional Medical Center". undefined are not yet recruiting, 68 are recruiting, 125 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Saint Francis Regional Medical Center, 6 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Francis Regional Medical Center, 9 "Phase 1" clinical trials were conducted, 150 "Phase 2" clinical trials and 136 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".

Saint Francis Regional Medical Center has several departments that took part in Clinical trials: "St. Francis Cancer Center at St. Francis Medical Center" - 134 trials